Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of November 9, 2026, TTRX trades at $9.50 with a market cap of $287.89M and a P/E ratio of -98.67. TTRX moved +0.20% today. Year to date, TTRX is +102.13%; over the trailing twelve months it is +123.06%. Its 52-week range spans $2.57 to $26.50. Analyst consensus is buy with an average price target of $16.67. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TTRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $9.50 |
| Market Cap | $287.89M |
| P/E Ratio | -98.67 |
| EPS | $-0.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.50 |
| 52-Week Low | $2.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-3.19M |
| Gross Margin | 0.00% |
3 analysts cover TTRX: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.67.